The Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center (MDSRC) of Seattle is a collaborative venture focused on preclinical and clinical studies for the two most common forms of muscular dystrophy: Duchenne (DMD) and facioscapulohumeral (FSHD). Scientists and clinicians at the University of Washington, Fred Hutchinson Cancer Research Center, Seattle Children’s Hospital, University of Rochester, University of Kansas Medical Center Research Institute, and University of Nevada Reno are working together to develop new strategies for patient care, treatments, and potential cures.